Benzyl(hexyl)carbamic acid

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: Benzyl(hexyl)carbamic acid
• 英文别名: benzyl(hexyl)carbamic acid
• 化学式: C₁₄H₂₁NO₂
• 分子量: 235.32
• InChiKey: HTVCUIILPVAPRS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  17
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  40.5
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• [EN] SYNTHETIC OLIGOSACCHARIDES FOR P. AERUGINOSA VACCINE<br/>[FR] OLIGOSACCHARIDES DE SYNTHÈSE POUR VACCIN CONTRE P. AERUGINOSA
  申请人：SYNGLYCO PHARMACEUTICALS INC

  公开号：WO2015002954A1

  公开（公告）日：2015-01-08

  The present invention provides synthetic Pseudomonas aeruginosa lipooligosaccharide (LOS)-based oligosaccharides and conjugates containing various P. aeruginosa serotype-specific oligosaccharide antigens or various core P. aeruginosa oligosaccharide structures or motifs. The invention further provides P. aeruginosa LOS-based immunogenic and immunoprotective compositions and antibodies derived therefrom for diagnosing, treating, and preventing infections caused by P. aeruginosa.

  本发明提供了合成的假单胞菌脂寡糖（LOS）基寡糖和含有不同假单胞菌血清型特异性寡糖抗原或不同核心假单胞菌寡糖结构或基序的共轭物。该发明还提供了基于假单胞菌LOS的免疫原和免疫保护组合物，以及由此衍生的抗体，用于诊断、治疗和预防由假单胞菌引起的感染。
• SYNTHETIC OLIGOSACCHARIDES FOR P. AERUGINOSA VACCINE
  申请人：SYNGLYCO, INC.

  公开号：EP2884842A1

  公开（公告）日：2015-06-24
• Synthetic Oligosaccharides for P. Aeruginosa Vaccine
  申请人：SynGlyco, Inc.

  公开号：US20150152129A1

  公开（公告）日：2015-06-04

  The present invention provides synthetic Pseudomonas aeruginosa lipooligosaccharide (LOS)-based oligosaccharides and conjugates containing various P. aeruginosa serotype-specific oligosaccharide antigens or various core P. aeruginosa oligosaccharide structures or motifs. The invention further provides P. aeruginosa LOS-based immunogenic and immunoprotective compositions and antibodies derived therefrom for diagnosing, treating, and preventing infections caused by P. aeruginosa.
• [EN] SYNTHETIC OLIGOSACCHARIDES FOR P. AERUGINOSA VACCINE<br/>[FR] OLIGOSACCHARIDES SYNTHÉTIQUES POUR VACCIN ANTI-P. AERUGINOSA
  申请人：ANCORA PHARMACEUTICALS INC

  公开号：WO2014014670A1

  公开（公告）日：2014-01-23

  The present invention provides synthetic Pseudomonasaeruginosa lipooligosaccharide (LOS)-based oligosaccharides and conjugates containing various P. aeruginosa serotype-specific oligosaccharide antigens or various core P. aeruginosa oligosaccharide structures or motifs. The invention further provides P. aeruginosa LOS-based immunogenic and immunoprotective compositions and antibodies derived therefrom for diagnosing, treating, and preventing infections caused by P. aeruginosa.